Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
M. Ruis, I. Mikulic, F. Tichelmann, O. C. Burghuber, A. Valipour (Vienna, Austria). Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea. Eur Respir J 2008; 32: Suppl. 52, 826

Member's Comments

No comment yet.

Related content which might interest you: Cardiovascular risk, insulin resistance and metabolic syndrome in patients with obstructive sleep apnea Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007 Obstructive sleep apnea syndrome and cardiovascular diseases risk in patients with COPD Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA Year: 2012 Investigation of various factors in obstructive sleep apnea syndrome patients Source: Eur Respir J 2006; 28: Suppl. 50, 194s Year: 2006 Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009 The prevalance of cardiovascular disorders in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 293s Year: 2002 Prevalence of metabolic syndrome from patient with obstructive sleep apnea and hypertension Source: International Congress 2019 – Current perspectives in sleep-disordered breathing Year: 2019 The evaluation of risk of obstructive sleep apnea syndrome in individuals with dysglycaemia Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology Year: 2012 The impact of obstructive sleep apnea syndrome on cardiovascular system in children Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain Year: 2011 Obstructive pulmonary disorder is a potential risk factor of cardiovascular diseases in obstructive sleep apnea Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008 Cardiovascular and metabolic consequences of obstructive sleep apnoea Source: Eur Respir J 2001; 18: Suppl. 33, 519s Year: 2001 The genetic and cardiovascular aspects of obstructive sleep apnoea/hypopnoea syndrome Source: Eur Respir J 2009; 33: 233-236 Year: 2009 Treatment control in risk patients with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 411s Year: 2006 The influence of obesity in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 295s Year: 2002 Impaired glucose tolerance and other cardiovascular risk factors in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009 Predictors of obstructive sleep apnea syndrome and metabolic syndrome Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism Year: 2011 Autoantibody against NBL1 in obstructive sleep apnea patients with cardiovascular disease Source: International Congress 2017 – New insights into the understanding of sleep and the consequences of sleep apnoea Year: 2017 The risk of future cardiovascular diseases in the patients with OSAS is dependently or independently associated with obstructive sleep apnoea Source: Eur Respir J 2001; 17: 573-574 Year: 2001 Risk factors of hypercapnia in patient with obstructive sleep apnea Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA Year: 2012 Obstructive sleep apnea syndrome as factor of arrhythmic syndrome emergence and increase of cardiovascular risk in patients with COPD Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing Year: 2013 Metabolic syndrome in obstructive sleep apnoea patients Source: Annual Congress 2007 - Sleep apnoea Year: 2007